Qiagen NV | QIA - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.07M 215K 2023-06
argenx SE USD 1000K 172K 2026-03
Avita Medical AUD 1.25M 100K 2025-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Ionis Pharmaceuticals USD 18M 1000K 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 108M 3M 2026-06
Qiagen NV USD 10.02M 1.03M 2026-06
Revvity USD 22.99M 1.73M 2026-06
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Viatris USD 120.7M 600K 2026-06
Xeris Pharmaceuticals USD 6.88M 269K 2026-03